With import restrictions now lifted after the resolution of a patent dispute, Ultrahuman re-enters the red-hot U.S. smart ring market, looking to compete with category leader Oura
Ultrahuman is officially back in the U.S., marking its return after a period of disruption tied to an International Trade Commission (ITC) import ban that had paused its ability to sell smart rings in the American market.
The ruling last year found that Ultrahuman and RingConn had infringed on category leader Oura’s patents related to smart ring design and technology.
With that restriction now resolved, the company has opened pre-orders for its Ring Pro following clearance from U.S. Customs and Border Protection, signaling a renewed push into one of the most competitive wearable categories. Shipping is set to begin May 15, with early pricing starting at $349 for the first tranche of customers.
The relaunch comes at a time when the booming smart ring category has become increasingly crowded and more tightly contested, particularly around questions of battery life, clinical relevance and recurring revenue models.
Ultrahuman’s positioning is offering a one-time hardware purchase with access to core health insights, without a mandatory subscription. Sleep, recovery, movement, stress and circadian data insights are all included.
The Ring Pro also delivers up to 15 days of battery life on a single charge, extending to more than 45 days when paired with the new Pro Charging Case. It also stores up to 250 days of health data directly on the device, reducing the need for syncing. The ring features a titanium design and a dual-core processor.
Founder and CEO Mohit Kumar framed the launch as both a technical milestone and a strategic return to the U.S. market.
“Ring Pro is a breakthrough in wearable technology, delivering category-defining battery life within the demanding constraints of a smart ring,” Kumar said. “We’re delighted to be back in the U.S., and engineering has prevailed, as it always does.”
While Ultrahuman is attempting to differentiate itself from competitors like Oura with the lack of subscription to use its ring, its “Power Plug” offerings are key for the company’s recurring revenue. These optional add-ons introduce more clinical capabilities, like AFib detection, ovulation tracking, respiratory and snoring analysis developed with Sleep Cycle, migraine insights and safety monitoring for users taking GLP-1 medications.
Pricing for Ring Pro follows a tiered pre-order structure, starting at $349 for the first 1,000 customers and scaling up to $449 before pre-orders close. After that, the ring will retail starting at $399, with the Pro Charging Case sold separately or bundled.
